Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
A new survey of US veterinarians has further underlined Seresto's place among leading the leading pet antiparasitics.
UK aquaculture health business Benchmark has raised proceeds of £43 million ($56 million) to scale up and launch new technologies.
Elanco has moved a step closer to completing its acquisition of Bayer Animal Health by agreeing its third divestment deal to satisfy anti-trust regulators.
Review 2019: US witnesses bumper year of veterinary approvals, while EU achieves milestone authorizations
In 2019, both the US and Europe saw several significant approvals in animal health. Animal Pharm analyst Sian Lazell gives an overview of the most notable products that were given the green light for their commercial debuts during the year.
MSD Animal Health has further built on the label of Bravecto (fluralaner) in Europe, with the product now approved to treat mite infestations in dogs.
Subscribers have five weeks to nominate their company and innovations as part of the Animal Pharm Awards for 2019.
Merck Animal Health's Bravecto Plus topical solution can now be used for cats in the US following FDA approval.
Boehringer Ingelheim Animal Health has invested nearly $50 million in the extension of its manufacturing site in Barceloneta, Puerto Rico.
Merck Animal Health is currently working on the development of a triple-action antiparasitic for pets – a potential blockbuster product.
Alivira Animal Health has gained WHO-Geneva approval for the manufacture of praziquantel-based anthelmintics at its facility in Vizag.
Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.
A new study by MSD Animal Health has highlighted new data on the impact of Exzolt – a parasiticide for poultry red mite infestations.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.